Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | GRM4 | Q14833 | 3/20 | 0.33 |
| ▸ | ERN1 | O75460 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3069763 | 0.85 | ERN1 (0.46) | KDM4EHTTGRM4ERN1 | |
| SCHEMBL3070258 | 0.84 | KDM4E (0.39) | KDM4EHTTMAPTRAB9ATDP1 | |
| SCHEMBL3061579 | 0.83 | KDM4E (0.39) | KDM4EHTTGRM4ERN1MAPT | |
| SCHEMBL3070590 | 0.81 | KDM4E (0.37) | KDM4EHTTMAPTRAB9AUSP30 | |
| SCHEMBL3062291 | 0.80 | KDM4E (0.37) | KDM4EHTTUSP30 | |
| SCHEMBL3065450 | 0.80 | HTT (0.39) | KDM4EHTTGRM4MAPTUSP30 | |
| SCHEMBL3068291 | 0.80 | KDM4E (0.44) | KDM4EHTTMAPTRAB9AUSP30 | |
| SCHEMBL3065398 | 0.80 | HTT (0.39) | KDM4EHTTGRM4MAPTUSP30 | |
| SCHEMBL3063518 | 0.80 | KDM4E (0.32) | KDM4EHTT | |
| SCHEMBL4508573 | 0.79 | KDM4E (0.42) | KDM4EHTTERN1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100261719-A1 | CHEMICAL COMPOUNDS | ASTRAZENECA AB (SE) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261719-A1 | CHEMICAL COMPOUNDS | NCOA3, NR4A3, NR0B2 | KDM4E 4486/4885HTT 2271/4885GRM4 2279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.